Iranian Journal of Pediatrics

Published by: Kowsar

Relationship Between Fecal Calprotectin and Upper Endoscopy Findings in Children With Upper Gastrointestinal Symptoms

Pedram Ataee 1 , Vahidreza Afrasiabi 2 , Bahram Nikkhoo 3 , Mehri Najafi Sani 4 , 5 , Ramesh Rahehagh 3 , Ebrahim Ghaderi 6 , Maryam Monajemzadeh 5 , 7 , Asadollah Fathollahpour 2 , Banafsheh Sedaghat 8 , Froozan Kariminejhad 9 , Jaleh Parizad 5 and Kambiz Eftekhari 10 , *
Authors Information
1 Liver and Digestive Research Center, Kurdistan University of Medical Sciences, Sanandaj, IR Iran
2 Department of Pediatrics, Kurdistan University of Medical Sciences, Sanandaj, IR Iran
3 Department of Pathology, Kurdistan University of Medical Sciences, Sanandaj, IR Iran
4 Department of Pediatrics, Tehran University of Medical Sciences, Tehran, IR Iran
5 Children’s Medical Center, Pediatrics Center of Excellence, Tehran, IR Iran
6 Social Determinants of Health Center, Kurdistan University of Medical Sciences, Sanandaj, IR Iran
7 Department of Pathology, Children’s Medical Center Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
8 Department of Pediatrics, Shariati Hospital, Social Security Organization, Isfahan, IR Iran
9 Department of Endoscopy, Kurdistan University of Medical Sciences, Sanandaj, IR Iran
10 Department of Pediatrics, Bahrami Children’s Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Iranian Journal of Pediatrics: June 2017, 27 (3); e8658
  • Published Online: February 8, 2017
  • Article Type: Research Article
  • Received: September 4, 2016
  • Revised: December 10, 2016
  • Accepted: January 13, 2017
  • DOI: 10.5812/ijp.8658

To Cite: Ataee P, Afrasiabi V, Nikkhoo B, Najafi Sani M, Rahehagh R, et al. Relationship Between Fecal Calprotectin and Upper Endoscopy Findings in Children With Upper Gastrointestinal Symptoms, Iran J Pediatr. 2017 ; 27(3):e8658. doi: 10.5812/ijp.8658.

Abstract
Copyright © 2017, Growth & Development Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
References
  • 1. Bishop WP. Nelson Essential of Pediatrics. 2006; : 581
  • 2. Gieteling MJ, Bierma-Zeinstra SM, Passchier J, Berger MY. Prognosis of chronic or recurrent abdominal pain in children. J Pediatr Gastroenterol Nutr. 2008; 47(3): 316-26[DOI][PubMed]
  • 3. Fagerberg UL, Loof L, Lindholm J, Hansson LO, Finkel Y. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2007; 45(4): 414-20[DOI][PubMed]
  • 4. Shahraki T, Farahmand F, Shahraki M, Karami H. Clinical and laboratory findings of celiac disease in patients referred to children medical center (tehran; iran). JBUMS. 2009; 11(4): 69-74
  • 5. El-Badry A, Sedrak H, Rashed L. Faecal calprotectin in differentiating between functional and organic bowel diseases. Arab J Gastroenterol. 2010; 11(2): 70-3[DOI]
  • 6. Montalto M, Gallo A, Santoro L, D'Onofrio F, Landolfi R, Gasbarrini A. Role of fecal calprotectin in gastrointestinal disorders. Eur Rev Med Pharmacol Sci. 2013; 17(12): 1569-82[PubMed]
  • 7. Vernuccio D, Melli P, Spagnut G, Celestino S, Collarile P, Tonutti E, et al. Functional and organic abdominal pain: Role of fecal calprotectin and common serum markers in the differential diagnosis. Dig Liver Dis. 2013; 45-1[DOI]
  • 8. Poullis A, Foster R, Mendall MA, Fagerhol MK. Emerging role of calprotectin in gastroenterology. J Gastroenterol Hepatol. 2003; 18(7): 756-62[PubMed]
  • 9. Grossman AB, Baldassano RN. Nelson Text Book of Pediatrics. 2016; : 1823
  • 10. Sidler MA, Leach ST, Day AS. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children. Inflamm Bowel Dis. 2008; 14(3): 359-66[DOI][PubMed]
  • 11. Manz M, Burri E, Rothen C, Tchanguizi N, Niederberger C, Rossi L, et al. Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study. BMC Gastroenterol. 2012; 12: 5[DOI][PubMed]
  • 12. Montalto M, Gallo A, Ianiro G, Santoro L, D'Onofrio F, Ricci R, et al. Can chronic gastritis cause an increase in fecal calprotectin concentrations? World J Gastroenterol. 2010; 16(27): 3406-10[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments